Inhibrx Biosciences (INBX) Leases: 2023-2025
Historic Leases for Inhibrx Biosciences (INBX) over the last 2 years, with Sep 2025 value amounting to $6.0 million.
- Inhibrx Biosciences' Leases rose 293.70% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 293.70%. This contributed to the annual value of $7.3 million for FY2024, which is 148.58% up from last year.
- According to the latest figures from Q3 2025, Inhibrx Biosciences' Leases is $6.0 million, which was down 7.06% from $6.5 million recorded in Q2 2025.
- In the past 5 years, Inhibrx Biosciences' Leases ranged from a high of $7.3 million in Q4 2024 and a low of $1.5 million during Q3 2024.
- Moreover, its 3-year median value for Leases was $6.0 million (2025), whereas its average is $4.7 million.
- Data for Inhibrx Biosciences' Leases shows a peak YoY surged of 293.70% (in 2025) over the last 5 years.
- Over the past 3 years, Inhibrx Biosciences' Leases (Quarterly) stood at $3.0 million in 2023, then soared by 148.58% to $7.3 million in 2024, then surged by 293.70% to $6.0 million in 2025.
- Its Leases stands at $6.0 million for Q3 2025, versus $6.5 million for Q2 2025 and $6.9 million for Q1 2025.